Lankenau Institute for Medical Research Awarded 5-Year Cancer Research Grant From the W.W. Smith Charitable Trust
Published: Sep 04, 2013
Wynnewood, Pa. (September 4, 2013) - The Lankenau Institute for Medical Research (LIMR), the research arm of Main Line Health, has been awarded a 5-year, $625,000 grant from the W.W. Smith Charitable Trust to initiate promising avenues of cancer research.
“We are incredibly excited about the research opportunities that will be afforded through this grant,” states George Prendergast, Ph.D., President and CEO of LIMR.
Researchers at LIMR are currently developing breast cancer diagnostic tools to improve patient care and outcomes. One project involves identifying markers for early stage breast cancers that are thought to be curable through conventional avenues of treatment, but are not. Another test being developed will determine whether the toxicity from chemotherapy would be too severe for a patient before they need to be admitted to the hospital for chemotherapy complications.
“Main Line Health is committed to providing the best cancer care to our communities,” affirms Dr. Prendergast, “and thanks to the generous funding of the W.W. Smith Charitable Trust, LIMR scientists can contribute to cancer research and treatments that may lead to medical breakthroughs.”
About The W.W. Smith Charitable Trust
The W. W. Smith Charitable Trust is a private local foundation established by William Wikoff Smith in 1977. A primary focus of the Trust is to fund basic medical research in the areas of heart disease, cancer and AIDS. To learn more about the W.W. Smith Charitable Trust, please visit www.wwsmithcharitabletrust.org.
About Lankenau Institute for Medical Research
Founded in 1927, the Lankenau Institute for Medical Research (LIMR) is an independent, nonprofit biomedical research center located in suburban Philadelphia on the campus of Lankenau Medical Center. Part of Main Line Health, LIMR is one of the few freestanding, hospital associated medical research centers in the nation. The faculty and staff at the Institute are dedicated to advancing an understanding of the causes of cancer, heart disease and diabetes. This information is used to help improve diagnosis and treatment of these diseases as well as find ways to prevent them. LIMR is also committed to extending the boundaries of human health and well-being through technology development and the training of the next generation of scientists and physicians. To learn about LIMR, visit www.limr.org.
Help employers find you! Check out all the jobs and post your resume.